Do care pathways using guideline-based best practices and team-based care improve rheumatoid arthritis outcomes? In an RA cohort, patients in the care pathway were more likely to achieve remission but had higher per member per month costs of care
AC&R
https://t.co/VnxG1Wk6D7
Dr. Tarun Sharma is now an Associate Professor of Medicine at @DrexelMedicine! In addition to his positive impact on the care and research of autoimmune patients and diseases, Dr. Sharma has made a major contribution to our academic mission.
When can medication be tapered in patients with stable #RheumatoidArthritis? Guest Edited by @MdTSharma, this mini supplement presents the real-world evidence.
Read now 👉 https://t.co/iy3JEu1jvW
Blog on my RA rx tapering research funded by the Virginia T. Ladd Young Investigator Program. Tapers that flared recaptured remission. MTX tapers didn’t do significantly worse than non-tapers. More flares in older and non Caucasian pts per univariate. https://t.co/vEUPYYSlWM
Your #RheumatoidArthritis is in remission: Now what? @MohamedTagMD@DrexelUniv team at #ACR21 explored how tapering meds (resulting in lower dose, frequency, or discontinuation) can impact remission following 346 #RA patients over a 2-year span.